Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain

被引:14
作者
Gonzalez-Serna, A. [1 ]
Macias, J. [1 ]
Palacios, R. [2 ]
Gomez-Ayerbe, C. [2 ]
Tellez, F. [3 ]
Rivero-Juarez, A. [4 ]
Fernandez, M. [1 ]
Santos, J. [4 ]
Real, L. M. [1 ]
Gonzalez-Domenech, C. M. [2 ]
Gomez-Mateos, J. [1 ]
Pineda, J. A. [1 ]
机构
[1] Hosp Univ Virgen Valme, Unidad Enfermedades Infecciosas & Microbiol, Avda Bellavista S-N, Seville 41014, Spain
[2] Hosp Univ Virgen Victoria, Unidad Enfermedades Infecciosas & Microbiol, Malaga, Spain
[3] Univ Cadiz, Hosp Univ Puerto Real, Dept Med, UGC Enfermedades Infecciosas, Cadiz, Spain
[4] Hosp Univ Reina Sofia, Unidad Enfermedades Infecciosas, Cordoba, Spain
关键词
hepatitis C virus; HIV; men who have sex with men; microelimination; risk factors; POSITIVE MEN; NEGATIVE MEN; SEX; OUTBREAK; HCV;
D O I
10.1111/hiv.13039
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives Spain is close to HCV microelimination, so rates of recently acquired HCV infection (RAHC) should decrease. Nowadays, men who have sex with men (MSM) carry the highest risk of HCV acquisition. Our aim was to estimate the incidence of and the factors associated with RAHC, together with reinfection rates, among patients sexually infected by HIV. Methods Primary RAHC infection was diagnosed when anti-HCV antibody seroconversion was documented. In anti-HCV positive patients, initially without HCV viraemia, a diagnosis of reinfection was established if plasma HCV RNA was detected. Results All 350 patients tested negative for anti-HCV at baseline and had at least one follow-up visit. Among them, there were 16 RAHC cases from 2016 to 2019. RAHC incidence rates [IR (95% confidence interval, CI)] per 100 person-years were 3.77 (0.5-12.9) in 2016, 1.85 (0.6-4.3) in 2017, 1.49 (0.4-3.8) in 2018 and 1.98 (0.6-4.5) in 2019. Only previous sexually transmitted infections [incidence rate ratio (IRR) = 18.23, 95% CI: 1.93-172.1; P = 0.011], male sex (IRR = 8.33, 95% CI: 1.38-54.15; P = 0.026) and sharing chem-sex drugs (IRR: 4.93, 95% CI: 1.17-20.76; P = 0.030), were independently associated with RAHC. Four out of 42 (9.5%) patients became reinfected. Conclusions The incidence of RAHC among HIV-infected patients showed a decrease after 2016, although a lower but steady incidence of residual cases still remains. HCV reinfections showed a similar pattern. New infections were associated with sharing chem-sex drugs among MSM.
引用
收藏
页码:379 / 386
页数:8
相关论文
共 38 条
  • [1] [Anonymous], 2017, GLOB HEP REP 2017
  • [2] Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice
    Arends, J. E.
    Kracht, P. A. M.
    Hoepelman, A. I. M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (10) : 846 - 852
  • [3] Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant
    Berenguer, Juan
    Jarrin, Inmaculada
    Perez-Latorre, Leire
    Hontanon, Victor
    Vivancos, Maria J.
    Navarro, Jordi
    Tellez, Maria J.
    Guardiola, Josep M.
    Iribarren, Jose A.
    Rivero-Juarez, Antonio
    Marquez, Manuel
    Artero, Arturo
    Morano, Luis
    Santos, Ignacio
    Moreno, Javier
    Farinas, Maria C.
    Galindo, Maria J.
    Hernando, Maria A.
    Montero, Marta
    Cifuentes, Carmen
    Domingo, Pere
    Sanz, Jose
    Domingez, Lourdes
    Ferrero, Oscar L.
    De la Fuente, Belen
    Rodriguez, Carmen
    Reus, Sergio
    Hernandez-Quero, Jose
    Gaspar, Gabriel
    Perez-Martinez, Laura
    Garcia, Coral
    Force, Lluis
    Veloso, Sergio
    Losa, Juan E.
    Vilaro, Josep
    Bernal, Enrique
    Arponen, Sari
    Orti, Amat J.
    Chocarro, Angel
    Teira, Ramon
    Alonso, Gerardo
    Silvarino, Rafael
    Vegas, Ana
    Geijo, Paloma
    Bisbe, Josep
    Esteban, Herminia
    Gonzalez-Garcia, Juan
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (01):
  • [4] Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy
    Boerekamps, Anne
    van den Berk, Guido E.
    Lauw, Fanny N.
    Leyten, Eliane M.
    van Kasteren, Marjo E.
    van Eeden, Arne
    Posthouwer, Dirk
    Claassen, Mark A.
    Dofferhoff, Anton S.
    Verhagen, Dominique W. M.
    Bierman, Wouter F.
    Lettinga, Kamilla D.
    Kroon, Frank P.
    Delsing, Corine E.
    Groeneveld, Paul H.
    Soetekouw, Robert
    Peters, Edgar J.
    Hullegie, Sebastiaan J.
    Popping, Stephanie
    van de Vijver, David A. M. C.
    Boucher, Charles A.
    Arends, Joop E.
    Rijnders, Bart J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (09) : 1360 - 1365
  • [5] Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
    Boesecke, Christoph
    Grint, Daniel
    Soriano, Vincent
    Lundgren, Jens D.
    Monforte, Antonella d'Arminio
    Mitsura, Victor M.
    Chentsova, Nelly
    Hadziosmanovic, Vesnadarjan
    Kirk, Ole
    Mocroft, Amanda
    Peters, Lars
    Rockstroh, Juergen K.
    [J]. LIVER INTERNATIONAL, 2015, 35 (11) : 2384 - 2391
  • [6] High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men
    Braun, Dominique L.
    Hampel, Benjamin
    Kouyos, Roger
    Huyen Nguyen
    Shah, Cyril
    Flepp, Markus
    Stockle, Marcel
    Conen, Anna
    Beguelin, Charles
    Kunzler-Heule, Patrizia
    Nicca, Dunja
    Schmid, Patrick
    Delaloye, Julie
    Rougemont, Mathieu
    Bernasconi, Enos
    Rauch, Andri
    Gunthard, Huldrych F.
    Boni, Jurg
    Fehr, Jan S.
    Anagnostopoulos, A.
    Battegay, M.
    Bucher, H. C.
    Calmy, A.
    Cavassini, M.
    Ciuffi, A.
    Dollenmaier, G.
    Egger, M.
    Elzi, L.
    Fellay, J.
    Furrer, H.
    Fux, C. A.
    Haerry, D.
    Hasse, B.
    Hirsch, H. H.
    Hoffmann, M.
    Hosli, I.
    Huber, M.
    Kahlert, C.
    Kaiser, L.
    Keiser, O.
    Klimkait, T.
    Kovari, H.
    Ledergerber, B.
    Martinetti, G.
    de Tejada, B. Martinez
    Marzolini, C.
    Metzner, K. J.
    Mueller, N.
    Paioni, P.
    Pantaleo, G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 (04) : 569 - 576
  • [7] Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencing
    Caro-Perez, Noelia
    Martinez-Rebollar, Maria
    Gregori, Josep
    Quer, Josep
    Gonzalez, Patricia
    Gambato, Martina
    Garcia-Gonzalez, Neris
    Gonzalez-Candelas, Fernando
    Costa, Josep
    Ignacio Esteban, Juan
    Mallolas, Josep
    Forns, Xavier
    Laguno, Montse
    Perez-del-Pulgar, Sofia
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2017, 92 : 42 - 47
  • [8] Prevalence and genotype distribution changes in hepatitis C virus co-infection among human immunodeficiency virus-infected patients
    Cifuentes, Celia
    Mancebo-Hernandez, Maria
    Perez-Navarro, Elisabet
    Recio, Eva
    Monje-Agudo, Patricia
    Valiente, Adoracion
    Pineda, Juan A.
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (02): : 110 - 112
  • [9] Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with men
    Cotte, Laurent
    Cua, Eric
    Reynes, Jacques
    Raffi, Francois
    Rey, David
    Delobel, Pierre
    Gagneux-Brunon, Amandine
    Jacomet, Christine
    Palich, Romain
    Laroche, Helene
    Cabie, Andre
    Hoen, Bruno
    Chidiac, Christian
    Pradat, Pierre
    [J]. LIVER INTERNATIONAL, 2018, 38 (10) : 1736 - 1740
  • [10] Garvey LJ, 2020, CLIN INFECT DIS, pciaa021